Old Web
English
Sign In
Acemap
>
Paper
>
Treatment of Post-transplant Relapse of FLT3-ITD Mutated AML Using 5-Azacytidine and Sorafenib Bitherapy
Treatment of Post-transplant Relapse of FLT3-ITD Mutated AML Using 5-Azacytidine and Sorafenib Bitherapy
2017
Selim Sid
Jerome Rey
Aude Charbonnier
Evelyne D'Incan
Bilal Mohty
Didier Blaise
Norbert Vey
Keywords:
Immunology
Sorafenib
Medicine
Internal medicine
flt3 itd
Oncology
post transplant
Correction
Source
Cite
Save
Machine Reading By IdeaReader
6
References
6
Citations
NaN
KQI
[]